TMC the Metals Company Reports $20.6 Million Net Loss in Q1 2026

TMC the Metals Company Inc. reported a net loss of $20.6 million for the first quarter of 2026, consistent with the loss of $20.6 million recorded in the same period of 2025. The company's total assets increased to $184.9 million as of March 31, 2026, compared to $181.6 million at the end of 2025. Cash reserves rose slightly to $119.7 million, up from $117.6 million, while total liabilities decreased to $212.2 million from $215.1 million. The company’s equity improved to a deficit of $27.3 million, compared to a deficit of $33.4 million at the end of the previous fiscal year.

Significant changes in operational expenses were noted, with exploration and evaluation expenses rising by 39% to $13.3 million, primarily due to increased share-based compensation and costs associated with prefeasibility studies. General and administrative expenses surged by 144% to $20.7 million, largely driven by higher share-based compensation and payroll costs. The company also recorded a dilution gain of $4.6 million from its investment in The Metals Royalty Company, reflecting a decrease in ownership percentage due to new share issuances by that entity.

TMC has made strategic advancements, including the submission of a consolidated application to the National Oceanic and Atmospheric Administration (NOAA) for exploration licenses and a commercial recovery permit covering approximately 65,000 square kilometers in the Clarion Clipperton Zone. This application received substantial compliance from NOAA, marking a key step in the regulatory process. Additionally, TMC entered into a Contract for Development Work and Commercial Production with Allseas, which includes the issuance of 7.4 million common shares to settle outstanding development costs.

The company continues to focus on its strategic partnerships, particularly with Allseas, to develop a commercial nodule collection system. TMC's operational strategy emphasizes the need for regulatory approvals and the establishment of processing facilities to convert polymetallic nodules into marketable products. The company remains in a pre-revenue stage, with expectations to generate revenue contingent upon receiving the necessary permits and successfully commencing commercial production.

Looking ahead, TMC anticipates ongoing operational losses as it advances its applications for commercial recovery permits and develops its nodule collection and processing technologies. The company is actively seeking additional financing to support its operations and has expressed confidence in its ability to meet its obligations over the next twelve months, although it acknowledges the potential need for further funding depending on business conditions and regulatory developments.